Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 9: New Drug Treatment & Technology

11:00 - 12:30 | 06 September | Room: Amphitheatre Havane

Back to Previous

11:00Clinical efficacy of eplerenone for central serous chorio-retinopathy – the VICI randomised trial
A. Lotery United Kingdom
11:06Combined intravitreal bevacizumab and fasudil (rock inhibitor) injection versus intravitreal injection of bevacizumab alone for macular edema secondary to central vein occlusion randomized clinical trial
R. Nourinia Iran, Islamic Republic of
11:12Duration of effect of ocular gene therapy: 4 year follow-up data from the phase III voretigene neparvovec trial in patients with biallelic RPE65 mutation associated retinal dystrophy
B. Leroy Belgium
11:18Efficacy of combined laser surgery in the treatment of horseshoe tears with subclinical retinal detachment
L. Kryl Russian Federation
11:24Electroretinogram-based temperature determination for non-damaging retinal laser treatments - a proof-of-concept with photopic pig ex vivo electroretinogram
O. Kaikkonen Finland
11:30Evaluation of baseline characteristics on lesion progression in a large phase 2 clinical trial for geographic atrophy (FILLY study)
I. Pearce United Kingdom
11:36A new two-step anesthesia for microincision vitrectomy surgery:a prospective, randomized clinical trial
W. Li China
11:42Functional near infra-red spectroscopy (fnirs) imaging of primary visual cortex activation in argus® ii retinal prosthesis subjects
Y. Luo United Kingdom
11:48Preparation and in vivo evaluation of nanoliposomes containing vancomycin after intravitreal injection in albino rabbits
M. Abrishami Iran, Islamic Republic of
11:54Pseudophakic cystoid macular edema prevention and risk factors; prospective study with a topical non-steroidal anti-inflammatory drug versus placebo
A. Praidou Greece
12:00Real Life experience with ozurdex in Colombian patients
H. Ocampo Colombia
12:06The small molecule integrin antagonist THR-687 potently inhibits ocular fibrosis in preclinical models
K. Beets Belgium
12:12Suprachoroidal injection of triamcinolone using a novel device
A. Aurora India
12:18Testing and first clinical results of a hydrogel-based artificial vitreous substitute
K. Januschowski Germany
Back to Previous

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved